The Form 4 filing, an SEC report of insider stock trades, was filed on November 12, 2026. The sale took place two days earlier, on November 10.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-10 |
| Date of Latest Transaction | 2026-11-10 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 16,035 |
| Price | $85.09 |
| Total Transaction Value | $1,364,437.39 |
| Insider | |
| Ticker Symbol | IRON |
| Company | Disc Medicine, Inc. |
| Insider Name | Savage William Jacob |
| Insider Title | Chief Medical Officer |
| Sector - Industry | Healthcare - Biotechnology |
| Holdings | |
| Total Shares Owned After Transaction | 63,445 |
| Position Size Change | 20.17% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of Disc Medicine (IRON) shares, reported with transaction code S. The record lists one sale by William Jacob Savage, the company's chief medical officer.
What was the average price of the transaction?
The average sale price was $85.0912 per share. Rounded to cents, that was $85.09 for each IRON share sold.
How did this transaction affect the insider's holdings?
William Jacob Savage sold 16,035 shares and reported owning 63,445 shares afterward. The sale accounted for 20.17% of the shares he owned before the trade.
What's the total transaction value?
The total sale value was $1,364,437.392, or $1,364,437.39 rounded to cents. This amount covers the single reported transaction.
Are there any special circumstances around this transaction?
The available filing information includes a Rule 10b5-1 trading-plan reference. These plans set trading instructions in advance. Footnote text was unavailable, so the details do not show whether a plan covered this specific sale. The plan's terms and the date it began remain unknown.
For research purposes only; not investment advice.